Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/20024169

Download in:

View as

General Info

PMID
20024169